The Potential of Human Mesenchymal Stem Cells

For this article, Eugene Russo interviewed Mark F. Pittenger, director of discovery research at Osiris Therapeutics. Data from the Web of Science (ISI, Philadelphia) show that Hot Papers are cited 50 to 100 times more often than the average paper of the same type and age. M.F. Pittenger, A.M. Mackay, S.C. Beck, R.K. Jaiswal, R. Douglas, J.D. Mosca, M.A. Moorman, D.W. Simonetti, S. Craig, D.R. Marshak, "Multilineage potential of adult human mesenchymal stem cells," Science, 284:143-7, April 2,

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

It was careful cell characterization, careful in vitro assays, and careful clonal analysis that contributed to the paper's impact, suggests Pittenger, who is now Osiris' director of discovery research. These elements together, he says, demonstrated that human mesenchymal stem cells (hMSCs) could be derived from bone marrow cells. Osiris investigators achieved differentiation into adipocytes (fat cells), chondrocytes (cartilage cells), and osteocytes (bone cells).

Initially, his group sought to generate in vitro assays that would be helpful in understanding cellular differentiation. "We went through a lot of literature, we tried a lot of different methods for differentiating the cells," he explains. "Some worked, some didn't." Then, through trial and error, they found the right combination of hormones, growth factors, vitamins, and serum and the correct methods to get the hMSCs to differentiate into each lineage. For example, to achieve adipocytic differentiation, the cells had to be confluent; whereas, too high a ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Eugene Russo

    This person does not yet have a bio.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide